Today: 26 April 2026
Subscribe
Browse Category

NYSE:NUVB 19 November 2025 - 11 December 2025

Nuvation Bio (NUVB) Soars After $18 Price-Target Hike – Is This High‑Growth Cancer Stock Still a Buy in 2025?

Nuvation Bio (NUVB) Soars After $18 Price-Target Hike – Is This High‑Growth Cancer Stock Still a Buy in 2025?

Nuvation Bio shares surged nearly 200% year-to-date, trading around $7.84 on December 11, 2025, after FDA approval of its lung cancer drug IBTROZI and strong analyst upgrades. H.C. Wainwright raised its price target to $18, citing higher revenue forecasts and clinical results. Average daily volume reached 8.7 million shares. The company reported 204 new patients started IBTROZI in Q3.
11 December 2025
Nuvation Bio (NUVB) Stock Soars ~50% Today as B. Riley Starts Coverage With $12 Target – 19 November 2025

Nuvation Bio (NUVB) Stock Soars ~50% Today as B. Riley Starts Coverage With $12 Target – 19 November 2025

Nuvation Bio shares surged about 50% to $7.20 in early afternoon trading Wednesday after B. Riley Securities initiated coverage with a “Buy” rating and $12 price target. The rally followed strong commercial results for lung cancer drug IBTROZI and coincided with management’s presentation at the Jefferies Global Healthcare Conference in London. Trading volume hit tens of millions of shares, lifting the company’s market cap to $2.4 billion.
19 November 2025
··

Stock Market Today

  • Gen Z Embraces High-Risk 'Alternative' Investments Amid Financial Pressure
    April 25, 2026, 10:08 PM EDT. Younger Americans, especially Gen Z and millennials, are increasingly drawn to high-risk alternative investments like crypto, meme stocks, sports betting, and prediction markets, according to Northwestern Mutual's 2026 Planning & Progress Study. Around 80% of Gen Z investors who choose risky assets feel financially behind, driving them towards speculative options believed to offer better growth prospects than traditional stocks and bonds. However, experts warn that many of these investments resemble gambling, with potentially negative expected returns and risks extending beyond financial losses. Notably, concerns have surfaced over speculative bets on sensitive political events, raising ethical questions. While crypto remains the most popular alternative, a substantial minority also engage in prediction markets and options trading, contrasting sharply with low participation from baby boomers.

Latest article

Lockheed Martin Gets Golden Dome Opening as Profit Worries Bite

Lockheed Martin Gets Golden Dome Opening as Profit Worries Bite

26 April 2026
Lockheed Martin was named among firms awarded up to $3.2 billion for President Trump’s Golden Dome space-based missile interceptor plan, Space Systems Command said. The company reported weaker first-quarter results, with $18 billion in sales and negative free cash flow. Space Force aims to show initial interceptor capability in 2028. Golden Dome’s total cost is projected at $185 billion.
ASML Stock’s AI Boom Has a Catch: TSMC Won’t Rush the $410 Million Machine

ASML Stock’s AI Boom Has a Catch: TSMC Won’t Rush the $410 Million Machine

26 April 2026
ASML shares rose 2.3% in Amsterdam late Friday as the company reported Q1 net sales of €8.8 billion and raised its 2026 sales outlook to up to €40 billion. TSMC, ASML’s top customer, said it would delay adopting ASML’s new High-NA EUV machines, priced at over €350 million each, preferring to extend use of existing tools. ASML aims to deliver at least 60 standard EUV machines in 2026.
Go toTop